HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarah E Church Selected Research

human ERBB2 protein

11/2021The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sarah E Church Research Topics

Disease

18Neoplasms (Cancer)
01/2023 - 09/2011
5Inflammation (Inflammations)
03/2024 - 10/2020
4Breast Neoplasms (Breast Cancer)
01/2023 - 09/2021
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2018
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 12/2016
2Rheumatoid Arthritis
03/2024 - 01/2022
2Infections
08/2023 - 03/2023
2Prostatic Neoplasms (Prostate Cancer)
01/2023 - 01/2022
2Microsatellite Instability
08/2022 - 03/2016
2Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 01/2020
2Cytokine Release Syndrome
01/2022 - 11/2021
1Lymphoma (Lymphomas)
10/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022
1COVID-19
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Sepsis (Septicemia)
01/2022
1Triple Negative Breast Neoplasms
08/2021
1Adenocarcinoma of Lung
11/2020
1Genomic Instability
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2018
1Leukemia
12/2016

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2017
4CytokinesIBA
01/2022 - 01/2014
4ChemokinesIBA
01/2022 - 01/2019
2NucleoproteinsIBA
08/2023 - 03/2023
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 12/2018
2AntigensIBA
01/2023 - 12/2016
2TamoxifenFDA LinkGeneric
01/2023 - 05/2022
2Chimeric Antigen ReceptorsIBA
10/2022 - 01/2022
2tocilizumab (atlizumab)FDA Link
01/2022 - 11/2021
2Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2020
1c-Mer Tyrosine KinaseIBA
03/2024
1Interleukin-6 (Interleukin 6)IBA
03/2024
1Phosphotransferases (Kinase)IBA
03/2024
1Tyrosine (L-Tyrosine)FDA Link
03/2024
1ParaffinIBA
01/2023
1Formaldehyde (Formol)FDA Link
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Estrogen ReceptorsIBA
01/2023
1venetoclaxIBA
10/2022
1Calcibiotic Root Canal SealerIBA
08/2022
1Hormones (Hormone)IBA
05/2022
1Phenobarbital (Luminal)FDA Link
05/2022
1Rituximab (Mabthera)FDA Link
01/2022
1Investigational DrugsIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1Calcineurin InhibitorsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Prostate-Specific Antigen (Semenogelase)IBA
01/2022
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022
1human ERBB2 proteinIBA
11/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2021
1insulin receptor-related receptor (IRR)IBA
11/2021
1Docetaxel (Taxotere)FDA Link
08/2021
1Interferon-gamma (Interferon, gamma)IBA
08/2021
1Carboplatin (JM8)FDA LinkGeneric
08/2021
1NivolumabIBA
11/2020
1RNA ProbesIBA
01/2020
1Immune Checkpoint InhibitorsIBA
11/2018
1vasectrin I (VS I)IBA
01/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
12/2016
1CalreticulinIBA
12/2016
1Indicators and Reagents (Reagents)IBA
03/2016
1VaccinesIBA
09/2011

Therapy/Procedure

10Immunotherapy
10/2022 - 01/2014
7Therapeutics
10/2022 - 10/2015
1Prostatectomy (Retropubic Prostatectomy)
01/2023
1Castration
01/2022
1Biological Therapy
01/2022
1Drug Tapering
11/2021
1Neoadjuvant Therapy
08/2021
1Drug Therapy (Chemotherapy)
01/2020